Xponance Inc. Buys 2,468 Shares of Aflac Incorporated (NYSE:AFL)

Xponance Inc. increased its position in Aflac Incorporated (NYSE:AFL - Free Report) by 3.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 80,118 shares of the financial services provider's stock after buying an additional 2,468 shares during the quarter. Xponance Inc.'s holdings in Aflac were worth $8,287,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of the company. Whipplewood Advisors LLC bought a new stake in Aflac in the fourth quarter valued at approximately $26,000. Darwin Wealth Management LLC bought a new stake in Aflac in the third quarter valued at approximately $34,000. BankPlus Trust Department bought a new stake in Aflac in the fourth quarter valued at approximately $34,000. Raelipskie Partnership bought a new stake in Aflac in the third quarter valued at approximately $38,000. Finally, Curio Wealth LLC bought a new stake in Aflac in the fourth quarter valued at approximately $36,000. Institutional investors own 67.44% of the company's stock.

Aflac Stock Performance

Shares of NYSE:AFL traded down $0.61 during midday trading on Friday, reaching $108.10. 5,333,576 shares of the company's stock traded hands, compared to its average volume of 1,996,221. The company has a market cap of $59.08 billion, a price-to-earnings ratio of 11.26, a P/E/G ratio of 3.24 and a beta of 0.93. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.08 and a current ratio of 0.10. Aflac Incorporated has a one year low of $79.31 and a one year high of $115.50. The stock has a 50 day moving average of $105.95 and a 200 day moving average of $107.63.

Remove Ads

Aflac (NYSE:AFL - Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. As a group, equities research analysts anticipate that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Insider Activity

In other Aflac news, EVP Audrey B. Tillman sold 24,744 shares of the stock in a transaction dated Friday, December 27th. The stock was sold at an average price of $103.40, for a total value of $2,558,529.60. Following the transaction, the executive vice president now owns 222,618 shares of the company's stock, valued at approximately $23,018,701.20. This represents a 10.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Joseph L. Moskowitz sold 1,000 shares of the stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $107.63, for a total value of $107,630.00. Following the completion of the transaction, the director now directly owns 25,393 shares in the company, valued at approximately $2,733,048.59. This represents a 3.79 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 55,546 shares of company stock valued at $5,863,616 over the last ninety days. 0.80% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

AFL has been the subject of several recent research reports. JPMorgan Chase & Co. boosted their price objective on Aflac from $90.00 to $94.00 and gave the company a "neutral" rating in a research report on Tuesday, January 7th. StockNews.com upgraded Aflac from a "sell" rating to a "hold" rating in a report on Friday, February 14th. BMO Capital Markets assumed coverage on Aflac in a report on Thursday, January 23rd. They set a "market perform" rating and a $111.00 target price for the company. Barclays decreased their target price on Aflac from $98.00 to $95.00 and set an "underweight" rating for the company in a report on Friday, February 7th. Finally, Evercore ISI decreased their target price on Aflac from $104.00 to $102.00 and set an "underperform" rating for the company in a report on Wednesday, December 4th. Two analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have issued a buy rating to the stock. According to MarketBeat, Aflac currently has an average rating of "Hold" and an average price target of $103.36.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.